Whipple's resection-proximal pancreaticoduodenectomy (PD)

Journal of the Royal College of Surgeons of Edinburgh

Volumn 47, Issue 3, 2002, Pages 528-540

  Tait, I S ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Complications; Pancreatic cancer; Pancreaticoduodenectomy; Staging; Technique; Whipple's resection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; DALTEPARIN; OCTREOTIDE; PROTON PUMP INHIBITOR;

ABDOMINAL ABSCESS; ANTIBIOTIC PROPHYLAXIS; CANCER ADJUVANT THERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; GASTROINTESTINAL HEMORRHAGE; HUMAN; LAPAROSCOPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PANCREAS FISTULA; PANCREATICODUODENECTOMY; PATIENT SELECTION; PEROPERATIVE ECHOGRAPHY; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; REVIEW; STOMACH EMPTYING; SURGEON; SURGICAL TECHNIQUE; SURVIVAL TIME;

ADENOCARCINOMA; ALGORITHMS; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM DISEASES; HUMANS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PATIENT SELECTION; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS;

EID: 0036081854     PISSN: 00358835     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (163)

1. Epidemiology of and risk factors for pancreatic cancer
2. New developments in pancreatic cancer
3. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct
4. Surgical bypass-versus metallic stent for unresectable pancreatic cancer
5. Expandable metal biliary stenting in patients with recurrent premature polyethylene stent occlusion
6. Endoscopic treatment of pancreatico-biliary malignancies
7. Endoscopic palliation for inoperable pancreatic cancer
8. Biliary and gastric bypass or stenting in nonresectable periampullary cancer: Analysis on the basis of controlled trials
9. Endoscopic pancreatic stenting in pancreatic cancer
10. Long-term results of endoscopic treatment of biliary duct obstruction due to pancreatic disease
11. Management of malignant biliary obstruction: Nonoperative and palliative techniques
12. Palliation of malignant obstructive jaundice. Use of self-expandable metal stents
13. Endoscopic biliary stenting for the palliation of pancreatic cancer: Results, survival predictive factors, and comparison of 10-French with 11.5-French gauge stents
14. Radiological intervention in pancreatic cancer
15. Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer
16. Biliary stenting versus bypass surgery for the palliation of malignant distal bile duct obstruction: A meta-analysis
17. Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s
18. Surgical palliation for ductal adenocarcinoma of the pancreas
19. Paclitaxel and concurrent radiation for locally advanced pancreatic cancer
20. Definitive results of a phase II trial of cisplatin, epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinoma
21. Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas
22. Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction
23. A systematic overview of chemotherapy effects in pancreatic cancer
24. Gemcitabine in advanced pancreatic cancer: A phase II trial
25. A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma
26. A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer
27. Gemcitabine combined with continuous infusion 5-fluorouracil in advanced and symptomatic pancreatic cancer: A clinical benefit-oriented phase II study
28. Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma
29. Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: A phase II study of the Greek Cooperative Group for Pancreatic Cancer
30. Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience
31. Pancreatic nodal metastases: Biologic significance and therapeutic considerations
32. Improving results of pancreaticoduodenectomy for pancreatic cancer
33. Periampullary adeno-carcinoma: Analysis of 5-year survivors
34. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes
35. Locoregional dissemination and extended lymphadenectomy in pancreatic cancer
36. Standards for pancreatic resection in the 1990s
37. Management of adenocarcinoma of the body and tail of the pancreas
38. Surgery for periampullary and pancreatic carcinoma: A Liverpool experience
39. Resection of pancreatic cancer-surgical achievements
40. The accuracy of EUS and helical CT in the assessment of vascular invasion by peripapillary malignancy
41. CT and MR imaging of pancreatic cancer
42. CT assessment of the inferior peripancreatic veins: Clinical significance
43. Is CT angiography sufficient for prediction of resectability of periampullary neoplasms?
44. Multidetector CT angiography in the evaluation of pancreatic carcinoma: Preliminary observations
45. MRI with mangafodipir trisodium in the detection and staging of pancreatic cancer
46. MRI with mangafodipir trisodium in the detection of pancreatic tumours: Comparison with helical CT
47. MR imaging of pancreatic masses
48. Preoperative evaluation of periampullary tumors by endoscopic sonography, transabdominal sonography, and computed tomography
49. Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma
50. Preoperative staging of periampullar cancer with US, CT, EUS and CA 19-9
51. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma
52. Peritoneal metastases in pancreatic carcinoma
53. Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer
54. Laparoscopy predicts metastatic disease and spares laparotomy in selected patients with pancreatic nonfunctioning islet cell tumors
55. Laparoscopy and peritoneal cytology in the staging of pancreatic cancer
56. Diagnostic laparoscopy combined with laparoscopic ultrasonography in staging of cancer of the pancreatic head region
57. The role of laparoscopy and ultra-sonography in pancreatic head carcinoma
58. Staging laparoscopy with laparoscopic ultrasonography: Optimizing resectability in hepatobiliary and pancreatic malignancy
59. Lesser sac endoscopy and laparoscopy in pancreatic carcinoma definitive diagnosis, staging and palliation
60. The use of diagnostic laparoscopy supported by laparoscopic ultrasonography in the assessment of pancreatic cancer
61. Laparoscopy with laparoscopic ultrasonography in the TNM staging of pancreatic carcinoma
62. Experience with laparoscopic ultrasonography for defining tumour resectability in carcinoma of the pancreatic head and periampullary region
63. Laparoscopy in the staging of pancreatic cancer
64. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units
65. Pylorus-preserving Whipple resection for pancreatic cancer. Is it any better?
66. Pancreatic cancer: The bigger picture
67. Personal observations, opinions, and approaches to cancer of the pancreas and the periampullary area
68. Cancer of the pancreas. Pylorus-preserving resection of the pancreas
69. A comparison of long term results of the standard Whipple procedure and the pylorus preserving pancreatoduodenectomy
70. Periampullary carcinoma detected after sphincterotomy
71. Randomized prospective trial of pylorus-preserving vs. Classic duodenopancreatectomy (Whipple procedure): Initial clinical results
72. Pylorus-preserving pancreaticoduodenectomy
73. Standard Kausch-Whipple pancreatoduodenectomy
74. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy
75. Laparoscopy for staging in pancreatic carcinoma
76. Carcinoma of the pancreatic head and periampullary region. Tumor staging with laparoscopy and laparoscopic ultrasonography
77. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy
78. The use of laparoscopic ultrasound in the assessment of pancreatic cancer
79. Ultrafast magnetic resonance imaging improves the staging of pancreatic tumors
80. Impact of laparoscopic staging in the treatment of pancreatic cancer
81. Staging laparoscopy promotes increased utilization of postoperative therapy for unresectable intra-abdominal malignancies
82. Essentials in biliopancreatic staging: A decision analysis
83. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial
84. The Mayo clinic approach to the surgical treatment of adenocarcinoma of the pancreas
85. Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms
86. CT and MR evaluation of pancreatic cancer
87. Pancreatic carcinoma: Imaging update 2001
88. The use of helical CT and CT angiography to predict vascular involvement from pancreatic cancer: Correlation with findings at surgery
89. Helical CT evaluation of arterial invasion in pancreatic tumors: Comparison with angiography
90. The role of diagnostic laparoscopy in pancreatic and periampullary malignancies
91. Workup of a patient with a mass in the head of the pancreas
92. Teardrop superior mesenteric vein: CT sign for unresectable carcinoma of the pancreas
93. How accurate is helical computed tomography for clinical staging of pancreatic cancer?
94. Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancer
95. Staging laparoscopy and laparoscopic ultrasonography in more than 400 patients with upper gastrointestinal carcinoma
96. Laparoscopic ultrasound enhances diagnostic laparoscopy in the staging of intra-abdominal neoplasms
97. Experience with staging laparoscopy in pancreatic malignancy
98. Staging laparoscopy for pancreatic cancer should be used to select the best means of palliation and not only to maximize the resectability rate
99. Improved tumor staging by diagnostic laparoscopy
100. Multifactorial index of cardiac risk in noncardiac surgery: Ten-year status report
101. A stepwise strategy for coronary risk assessment for noncardiac surgery
102. Preoperative cardiac risk assessment for patients having peripheral vascular surgery
103. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery
104. Perioperative myocardial infarction with noncardiac surgery
105. Physician estimates of perioperative cardiac risk in patients undergoing noncardiac surgery
106. Prospective evaluation of cardiac risk indices for patients undergoing noncardiac surgery
107. Role of video-laparoscopy in the staging of intra-abdominal lymphomas and gastrointestinal cancer
108. Routine diagnostic laparoscopy is unnecessary in staging tumors of the pancreatic head
109. Laparoscopy for pancreatic cancer: Does it benefit the patient?
110. Laparoscopic ultrasonography for staging of gastrointestinal malignancy
111. Is laparoscopic evaluation of digestive cancers legitimate? A prospective study of 109 cases
112. Preoperative diagnostic in pancreatic carcinoma: Would less be better?
113. Pancreatic cancer. Laparoscopic staging and peritoneal cytology
114. TNM staging and assessment of resectability of pancreatic cancer by laparoscopic ultrasonography
115. A critical appraisal of laparoscopic staging in hepatobiliary and pancreatic malignancy
116. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas
117. Laparoscopy and laparoscopic ultrasonography for staging pancreatic cancer: Critical appraisal
118. Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass
119. Surgical palliative treatment in bilio-pancreatic malignancy
120. Palliation of malignant gastric outlet obstruction with self-expanding metal stents
121. Laparoscopic biliary and gastric bypass: A useful adjunct in the treatment of carcinoma of the pancreas
122. Laparoscopic treatment of pancreatic disorders: Diagnosis and staging, palliation of cancer and treatment of pancreatic pseudocysts
123. Open versus laparoscopic gastrojejunostomy for palliation in advanced pancreatic cancer
124. Laparoscopic gastrojejunostomy in the palliation of pancreatic cancer: Reflections on the preliminary results
125. Clinical outcome of the use of enteral stents for palliation of patients with malignant upper GI obstruction
126. Preoperative staging and assessment of resectability of pancreatic cancer
127. Technical aspects of left-sided pancreatic resection for cancer
128. A preoperative biliary stent is associated with increased complications after pancreatoduodenectomy
129. Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy
130. Preoperative biliary drainage: Impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy
131. Effect of preoperative biliary drainage on surgical outcome after pancreatoduodenectomy
132. Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients
133. The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy
134. Laparoscopic screening of surgical candidates with pancreatic cancer or liver tumors
135. Risk analysis of pancreatic fistula after pancreatic head resection
136. Prophylaxis of complications after pancreatic surgery: Results of a multicenter trial in Germany
137. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: A pros-pective, controlled, randomized clinical trial
138. Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders
139. Results of duct-to-mucosa pancreaticojejunostomy for pancreaticoduodenectomy Billroth I type reconstruction in 100 consecutive patients
140. Trends in indications and outcomes in the Whipple procedure over a 40-year period
141. Complications after resection of biliopancreatic cancer
142. Ten-year experience with 733 pancreatic resections: Changing indications, older patients, and decreasing length of hospitalization
143. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation
144. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study
145. Experience with the Whipple procedure (pancreaticoduodenectomy) in a university-affiliated community hospital
146. Hemorrhage after pancreatoduodenectomy
147. Arterial hemorrhage after pancreatoduodenectomy. The 'sentinel bleed'
148. Successful nonoperative management of bleeding hepatic artery pseudoaneurysm following pancreaticoduodenectomy
149. Pancreaticojejunostomy versus pancreatico gastrostomy in reconstruction following pancreaticoduodenectomy
150. Computed tomography for pancreatic diseases
151. Management of complications following pancreaticoduodenectomy
152. Prevention and treatment of complications in pancreatic cancer surgery
153. Pancreatic fistula after pancreaticoduodenectomy: A comparison between patients with periampullary tumors and chronic pancreatitis
154. Octreotide for treatment of postoperative alimentary tract fistulas
155. The Whipple procedure in the 1990s
156. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: Treatment variables and survival duration
157. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group Study
158. Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: Results of a feasibility study
159. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer
160. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial
161. Adjuvant chemoradiotherapy for "unfavorable" carcinoma of the ampulla of Vater: Preliminary report
162. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and peri-ampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group
163. Adjuvant therapy for pancreatic cancer